Clinical documentation of end-stage renal disease due to hypertension.
about
Hypertension and chronic kidney disease: controversies in pathogenesis and treatmentHuman nephrosclerosis triggers a hypoxia-related glomerulopathySources of Urinary Proteins and their Analysis by Urinary Proteomics for the Detection of Biomarkers of DiseaseEnd-stage renal disease (ESRD) and vascular access grafting: a critical review.Essential hypertension and risk of nephropathy: a reappraisal.Genetic basis of nondiabetic end-stage renal diseaseThe kidney as a target of hypertension.The spectrum of MYH9-associated nephropathyThe population genetics of chronic kidney disease: insights from the MYH9-APOL1 locus.Target organ damage in African American hypertension: role of APOL1.Chromogranin A polymorphisms are associated with hypertensive renal disease.Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.Risk factors for end-stage renal disease: 25-year follow-upPolymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study.Epidemiology of hypertensive kidney disease.Rethinking hypertensive kidney disease: arterionephrosclerosis as a genetic, metabolic, and inflammatory disorder.Nephrosclerosis: update on a centenarian.A Case-Based Analysis of Whether Living Related Donors Listed for Transplant Share ESRD Causes with Their Recipients.'Normal for now' or 'at future risk': a double standard for selecting young and older living kidney donors.Kidney length in healthy members of Balkan endemic nephropathy families.Multiple myeloma after kidney transplantation.Insulin resistance and pancreatic beta-cell function in patients with hypertensive kidney disease.Urinary protein patterns in patients with Balkan endemic nephropathy.Pattern of hypertensive kidney disease in a black Kenyan population.Investigation into the underlying molecular mechanisms of hypertensive nephrosclerosis using bioinformatics analyses.
P2860
Q26851271-1A664C8E-A24F-4F04-AA57-872FC1CFE23BQ33597077-72928A19-F818-4047-A6E0-1F2E71A4EB9EQ33597457-A7CD6AEA-154C-488A-8598-7BC1E014BB87Q33642636-960C33FC-D006-4305-A4DC-0179B9C7C2CDQ33997784-937C5F3B-9692-404E-A7C4-4759C14F9777Q34018541-9DFAFC18-892F-45D3-B359-E38DCB52EA8BQ34028197-E9D6AAA9-DE42-4520-A880-365FC5488451Q34105121-9F94CB46-D584-4ADC-A3C9-726182BE87E9Q34182007-06CF3118-B7EA-42D8-BC92-C4B34B68DCE4Q35658743-0B15DDE2-21D7-41C8-83C0-D8B0BE663827Q36667220-2948C204-EEDC-4F9A-8912-7A311401386EQ37232156-86C9B99B-A720-47BE-BA69-657C3C007FCEQ37307169-1CAF376D-86A4-4B09-B58E-63C18CD112F1Q37359254-C5A3663F-9A4B-43B3-B400-DA9B879C9915Q37809748-D63584F4-AC41-4BC2-9492-EDB912B5E332Q38087486-0000FF05-46D7-43C0-B65E-48917838D5C7Q38285618-CC8F9D24-49EE-4806-8596-4D4484FE303EQ38935031-A0CE3C62-4C28-4B25-B827-81A5000177A2Q39895483-B91E3142-1BE5-459F-B172-650353DF316DQ41155276-67A57253-62FB-4114-B0F2-6AAF33B5748CQ43664893-32F37240-984A-4AF4-9695-5D44BE028688Q44976978-16FDC0DD-84E3-46C7-91EA-01E730634484Q45790050-400325C8-9BF5-415E-A832-012750133B59Q46808745-06B98F69-40F5-44DC-AEE7-D2D2901467BCQ50068087-532FC239-54A5-4FF0-9876-051F5E0813A3
P2860
Clinical documentation of end-stage renal disease due to hypertension.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Clinical documentation of end-stage renal disease due to hypertension.
@en
type
label
Clinical documentation of end-stage renal disease due to hypertension.
@en
prefLabel
Clinical documentation of end-stage renal disease due to hypertension.
@en
P2093
P1476
Clinical documentation of end-stage renal disease due to hypertension.
@en
P2093
Schlessinger SD
Tankersley MR
P304
P356
10.1016/S0272-6386(12)70275-5
P577
1994-05-01T00:00:00Z